A Sequence-randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between CKD-501 and Metformin After Oral Administration in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2012
At a glance
- Drugs Lobeglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 14 Jun 2012 Results published in Current Medical Research and Opinion.
- 05 Mar 2011 Results presented at the 112th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 11 Jan 2011 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.